Minor viral population with drug-resistant mutation and risk of persistent low-level viremia or 'blips' in HIV-1 subtype C

被引：3
作者：
Neogi, Ujjwal [1 ]
Sonnerborg, Anders [1 ,2 ]
机构：
[1] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden
[2] Karolinska Inst, Infect Dis Unit, Dept Med Huddinge, Stockholm, Sweden
来源：
AIDS | 2014年 / 28卷 / 17期
关键词：
ANTIRETROVIRAL THERAPY;
D O I：
10.1097/QAD.0000000000000463
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2635 / 2636
页数：2
相关论文
共 6 条
  • [1] Ekici H, 2014, J ANTIMICROB CHEMOTH
  • [2] Effect of HIV-1 Subtype on Virologic and Immunologic Response to Starting Highly Active Antiretroviral Therapy
    Geretti, Anna Maria
    Harrison, Linda
    Green, Hannah
    Sabin, Caroline
    Hill, Teresa
    Fearnhill, Esther
    Pillay, Deenan
    Dunn, David
    [J]. CLINICAL INFECTIOUS DISEASES, 2009, 48 (09) : 1296 - 1305
  • [3] Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naive populations and associate with reduced treatment efficacy
    Johnson, Jeffrey A.
    Li, Jin-Fen
    Wei, Xierong
    Lipscomb, Jonathan
    Irlbeck, David
    Craig, Charles
    Smith, Amanda
    Bennett, Diane E.
    Monsour, Michael
    Sandstrom, Paul
    Lanier, E. Randall
    Heneine, Walid
    [J]. PLOS MEDICINE, 2008, 5 (07) : 1112 - 1122
  • [4] Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure A Systematic Review and Pooled Analysis
    Li, Jonathan Z.
    Paredes, Roger
    Ribaudo, Heather J.
    Svarovskaia, Evguenia S.
    Metzner, Karin J.
    Kozal, Michael J.
    Hullsiek, Kathy Huppler
    Balduin, Melanie
    Jakobsen, Martin R.
    Geretti, Anna Maria
    Thiebaut, Rodolphe
    Ostergaard, Lars
    Masquelier, Bernard
    Johnson, Jeffrey A.
    Miller, Michael D.
    Kuritzkes, Daniel R.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (13): : 1327 - 1335
  • [5] Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients
    Metzner, Karin J.
    Scherrer, Alexandra U.
    von Wyl, Viktor
    Boeni, Juerg
    Yerly, Sabine
    Klimkait, Thomas
    Aubert, Vincent
    Furrer, Hansjakob
    Hirsch, Hans H.
    Vernazza, Pietro L.
    Cavassini, Matthias
    Calmy, Alexandra
    Bernasconi, Enos
    Weber, Rainer
    Guenthard, Huldrych F.
    [J]. AIDS, 2014, 28 (15) : 2231 - 2239
  • [6] Pre-existing Minority Drug-Resistant HIV-1 Variants, Adherence, and Risk of Antiretroviral Treatment Failure
    Paredes, Roger
    Lalama, Christina M.
    Ribaudo, Heather J.
    Schackman, Bruce R.
    Shikuma, Cecilia
    Giguel, Francoise
    Meyer, William A., III
    Johnson, Victoria A.
    Fiscus, Susan A.
    D'Aquila, Richard T.
    Gulick, Roy M.
    Kuritzkes, Daniel R.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (05) : 662 - 671
1